The markets traded mixed during the midday with the Dow rising 12 points to 10,334 after seven European banks out of a total of 91 failed stress tests. Nasdaq lost 6 points to 2239.
On the upside
Infinera (Nasdaq: INFN) narrowed second quarter losses as revenue soared.
Second quarter earnings fell for AthenaHealth (Nasdaq: ATHN) but the results beat expectations.
The Food and Drug Administration approved Momenta Pharmaceuticals' (Nasdaq: MNTA) generic version of Sanofi-Aventis' blood thinner Lovenox(R).
On the downside
Although first quarter earnings rose for QLogic (Nasdaq: QLGC), revenue fell short of expectations.
Great Atlantic & Pacific Tea (NYSE: GAP) widened first quarter losses as revenue dropped and the supermarket chain announced the replacement of chief executive Ron Marshall with Sam Martin.
Gleacher & Co. (Nasdaq: GLCH) disappointed by swinging to a second quarter loss.
In the broad market, advancing issues outpaced decliners by a margin of more than 9 to 7 on the NYSE and by nearly 5 to 4 on Nasdaq. The Russell 2000 which tracks small cap stocks added 3 points to 638.
